Aripiprazole reduces serum prolactin in a woman with prolactinoma and acute psychosis

Pharmacopsychiatry

Volumn 41, Issue 4, 2008, Pages 160-

  Sheldrick, A J ^a   Grunder G ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BROMOCRIPTINE; PROLACTIN; RISPERIDONE;

ACUTE PSYCHOSIS; ADULT; AUDITORY HALLUCINATION; CASE REPORT; DRUG CONTRAINDICATION; DRUG MECHANISM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; INSOMNIA; KAZAKHSTAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANOIA; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; REMISSION; RESTLESSNESS; VISUAL DISORDER;

ADULT; FEMALE; HUMANS; PIPERAZINES; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; PSYCHOTIC DISORDERS; QUINOLONES;

EID: 49249121533     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1076721     Document Type: Letter

References (5)

1. Brunelleschi S, Zeppegno P, Risso F, Cattaneo CI, Torre E. Risperidone-associated hyperprolactinemia: Evaluation in twenty psychiatric outpatients. Pharmacol Res 2003; 48: 405-409
2. Koch M. On the effects of partial agonists of dopamine receptors for the treatment of schizophrenia. Pharmacopsychiatry 2007; 40: 34-39
3. Lee B-H, Kim Y-K, Park S-H. Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study. Prog Neuro-Psychopharmacol Biol Psychiat 2006; 30: 714-717
4. Leuner K, Müller WE. The complexity of the dopaminergic synapses and their modulation by antipsychotics. Pharmacopsychiatry 2006; 39 (Suppl 1): 15-20
5. Szarfman A, Tonning JM, Levine JG, Doraiswamy PM. Atypical antipsychotics and pituitary tumors: A pharmacovigilance study. Pharmacotherapy 2006; 26: 748-758